Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LRMR Larimar Therapeutics, Inc.

休市中 12-05 16:00:00 EST

3.70

+0.02

+0.54%

盘后3.70

+0.000.00%

18:34 EST

最高3.80	最低3.66	成交量62.34万
今开3.72	昨收3.68	日振幅3.80%
总市值3.17亿	流通市值1.67亿	总股本8,559万
成交额231.16万	换手率1.38%	流通股本4,515万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LRMR","market":"US","secType":"STK","nameCN":"Larimar Therapeutics, Inc.","latestPrice":3.7,"timestamp":1764968400000,"preClose":3.68,"halted":0,"volume":623377,"hourTrading":{"tag":"盘后","latestPrice":3.7,"preClose":3.7,"latestTime":"18:34 EST","volume":1513,"amount":5599.62,"timestamp":1764977652679},"delay":0,"floatShares":45149399,"shares":85590392,"eps":-1.953372,"marketStatus":"休市中","change":0.02,"latestTime":"12-05 16:00:00 EST","open":3.72,"high":3.8,"low":3.66,"amount":2311610.0199735,"amplitude":0.038043,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.953372,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1403150400000,"exchange":"NASDAQ","adjPreClose":3.68,"preHourTrading":{"tag":"盘前","latestPrice":3.69,"preClose":3.68,"latestTime":"09:00 EST","volume":4736,"amount":17475.84,"timestamp":1764943215094},"postHourTrading":{"tag":"盘后","latestPrice":3.7,"preClose":3.7,"latestTime":"18:34 EST","volume":1513,"amount":5599.62,"timestamp":1764977652679},"volumeRatio":0.3360556750733484,"impliedVol":1.6717,"impliedVolPercentile":0.504},"requestUrl":"/m/hq/s/LRMR","defaultTab":"news","newsList":[{"id":"2579463458","title":"Larimar Therapeutics, Inc.盘中异动 快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579463458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579463458?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:56","pubTimestamp":1761850585,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日02时56分，Larimar Therapeutics, Inc.股票出现波动，股价急速下跌5.10%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家临床阶段的生物技术公司，专注于利用其创新的细胞穿透肽技术平台，为患有复杂罕见疾病的患者开发治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031025625974ace4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031025625974ace4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","LRMR","BK4007"],"gpt_icon":0},{"id":"1122274269","title":"生物制药概念股普涨， APLT暴涨24%，LRMR涨16%，阿斯利康涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122274269","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122274269?lang=zh_cn&edition=full","pubTime":"2025-10-01 22:15","pubTimestamp":1759328132,"startTime":"0","endTime":"0","summary":"再生元制药公司涨6.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3953510fd7eeb47ed4578bf140220b88","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","ARCT","LRMR","APLT"],"gpt_icon":0},{"id":"1163326758","title":"Larimar Therapeutics, Inc.盘前重挫52% 公司公布遗传疾病治疗药物长期晚期试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1163326758","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163326758?lang=zh_cn&edition=full","pubTime":"2025-09-29 19:16","pubTimestamp":1759144600,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics, Inc.股价在盘前交易中暴跌52%，此前该公司发布了其遗传疾病治疗药物的长期晚期阶段试验数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRMR","BK4139"],"gpt_icon":0},{"id":"1192277906","title":"Larimar Therapeutics公布正在进行的长期开放标签研究积极数据，并更新弗里德雷希共济失调症Nomlabofusp项目进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1192277906","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192277906?lang=zh_cn&edition=full","pubTime":"2025-09-29 19:01","pubTimestamp":1759143708,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics公布正在进行的长期开放标签研究积极数据，并更新弗里德雷希共济失调症Nomlabofusp项目进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRMR","BK4139"],"gpt_icon":0},{"id":"1123008388","title":"Larimar Therapeutics宣布召开Nomlabofusp治疗弗里德赖希共济失调症项目电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1123008388","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123008388?lang=zh_cn&edition=full","pubTime":"2025-09-29 05:01","pubTimestamp":1759093275,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics宣布召开Nomlabofusp治疗弗里德赖希共济失调症项目电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LRMR"],"gpt_icon":0},{"id":"2570877300","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570877300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570877300?lang=zh_cn&edition=full","pubTime":"2025-09-25 00:36","pubTimestamp":1758731819,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日00时36分，Larimar Therapeutics, Inc.股票出现波动，股价急速拉升5.07%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家临床阶段的生物技术公司，专注于利用其创新的细胞穿透肽技术平台，为患有复杂罕见疾病的患者开发治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092500365997a76bc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092500365997a76bc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2557538621","title":"Larimar Therapeutics, Inc.8月6日成交额为739.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557538621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557538621?lang=zh_cn&edition=full","pubTime":"2025-08-07 11:44","pubTimestamp":1754538278,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Larimar Therapeutics, Inc.成交额为739.31万美元，成交额较昨日减少73.90%，当日成交量为200.03万股。Larimar Therapeutics, Inc.于2025年8月6日涨0.8%，报3.77美元，该股过去5个交易日涨5.6%，年初至今跌2.58%，过去60日涨77.83%。其主打候选产品 CTI-1601 是一种皮下注射的重组融合蛋白，旨在将人类铁硫蛋白这种必需蛋白递送至弗里德赖希共济失调症患者的线粒体中。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807114439a479fd39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807114439a479fd39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","BK4539","LENZ","BK4007"],"gpt_icon":0},{"id":"2557344282","title":"Larimar Therapeutics, Inc.8月5日成交额为2832.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557344282","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557344282?lang=zh_cn&edition=full","pubTime":"2025-08-06 11:38","pubTimestamp":1754451502,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Larimar Therapeutics, Inc.成交额为2832.26万美元，成交额较昨日增加465.86%，当日成交量为723.78万股。Larimar Therapeutics, Inc.于2025年8月5日涨12.99%，报3.74美元，该股过去5个交易日涨5.95%，年初至今跌3.36%，过去60日涨66.96%。其主打候选产品 CTI-1601 是一种皮下注射的重组融合蛋白，旨在将人类铁硫蛋白这种必需蛋白递送至弗里德赖希共济失调症患者的线粒体中。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806113828a477ce6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806113828a477ce6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","LRMR","BK4539"],"gpt_icon":0},{"id":"2513733657","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513733657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513733657?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:38","pubTimestamp":1740411516,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时38分，Larimar Therapeutics, Inc.股票出现波动，股价大幅下挫5.02%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233836962ea893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233836962ea893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2512667111","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.39%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512667111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512667111?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分，Larimar Therapeutics, Inc.股票出现异动，股价急速拉升5.39%。截至发稿，该股报3.52美元/股，成交量5.0239万股，换手率0.08%，振幅4.94%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225028abd3b3a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225028abd3b3a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2508450756","title":"Larimar Therapeutics, Inc.盘中异动 早盘股价大涨5.01%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508450756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508450756?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:03","pubTimestamp":1738681407,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时03分，Larimar Therapeutics, Inc.股票出现异动，股价急速上涨5.01%。截至发稿，该股报3.73美元/股，成交量3.8992万股，换手率0.06%，振幅4.23%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042303279617dd04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042303279617dd04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2507463516","title":"Larimar Therapeutics(LRMR.US)获Truist Securities首次覆盖，给予买入评级, 目标价18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507463516","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507463516?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:35","pubTimestamp":1738157713,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics(LRMR.US)获Truist Securities首次覆盖，给予买入评级, 目标价18.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29213547898192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","LRMR"],"gpt_icon":0},{"id":"2503864263","title":"Larimar Therapeutics, Inc.盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503864263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503864263?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Larimar Therapeutics, Inc.股票出现异动，股价急速上涨5.47%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.06%、52.88%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为14.29%、12.00%、10.72%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232189604b414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232189604b414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"gpt_icon":0},{"id":"2503830295","title":"Larimar Therapeutics, Inc.盘中异动 早盘急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503830295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503830295?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:36","pubTimestamp":1736779004,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时36分，Larimar Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3523.95%、2133.17%、393.34%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、61.54%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223644a22040e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223644a22040e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","BK4139","LENZ"],"gpt_icon":0},{"id":"2500240111","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500240111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500240111?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:36","pubTimestamp":1735914997,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时36分，Larimar Therapeutics, Inc.股票出现异动，股价大幅拉升5.24%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223637a2146a2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223637a2146a2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LRMR","BK4139"],"gpt_icon":0},{"id":"2491134694","title":"Larimar Therapeutics, Inc.盘中异动 大幅跳水36.14%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491134694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491134694?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359476,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.股票出现异动，股价大幅下跌36.14%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"gpt_icon":0},{"id":"2490801276","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅下跌5.33%报6.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490801276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490801276?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:31","pubTimestamp":1733844668,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时31分，Larimar Therapeutics, Inc.股票出现波动，股价急速下跌5.33%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1918.05%、439.66%、125.47%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Uniqure N.V.，振幅分别为154.91%、131.78%、42.77%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023310895e8b152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023310895e8b152&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LRMR","LENZ"],"gpt_icon":0},{"id":"2486503832","title":"Larimar Therapeutics, Inc.盘中异动 早盘大幅拉升5.03%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486503832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486503832?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:40","pubTimestamp":1732545653,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时40分，Larimar Therapeutics, Inc.股票出现波动，股价急速拉升5.03%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224053a25491e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224053a25491e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2480691581","title":"Larimar Therapeutics, Inc.盘中异动 大幅下挫5.43%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480691581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480691581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:37","pubTimestamp":1730731034,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时37分，Larimar Therapeutics, Inc.股票出现异动，股价快速跳水5.43%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223714a2154b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223714a2154b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"gpt_icon":0},{"id":"2480885806","title":"Larimar Therapeutics, Inc.盘中异动 下午盘股价大跌5.17%报7.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480885806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480885806?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:58","pubTimestamp":1730483938,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时58分，Larimar Therapeutics, Inc.股票出现波动，股价急速下挫5.17%。截至发稿，该股报7.80美元/股，成交量16.0319万股，换手率0.25%，振幅6.57%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201585898e40113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201585898e40113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LRMR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.larimartx.com","stockEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.1491},{"period":"3month","weight":-0.0609},{"period":"6month","weight":0.3806},{"period":"1year","weight":-0.3854},{"period":"ytd","weight":-0.0439}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Larimar Therapeutics, Inc.，于2005年11月22日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于利用公司新型细胞穿透肽（“CPP”）技术平台为患有复杂罕见疾病的患者开发治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.102481},{"month":2,"riseRate":0.545455,"avgChangeRate":0.052852},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.145103},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.028256},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.091938},{"month":6,"riseRate":0.545455,"avgChangeRate":0.006336},{"month":7,"riseRate":0.5,"avgChangeRate":-0.021968},{"month":8,"riseRate":0.5,"avgChangeRate":0.081374},{"month":9,"riseRate":0.416667,"avgChangeRate":0.000938},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.029427},{"month":11,"riseRate":0.583333,"avgChangeRate":0.038429},{"month":12,"riseRate":0.583333,"avgChangeRate":0.048059}],"exchange":"NASDAQ","name":"Larimar Therapeutics, Inc.","nameEN":"Larimar Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Larimar Therapeutics, Inc.(LRMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Larimar Therapeutics, Inc.,LRMR,Larimar Therapeutics, Inc.股票,Larimar Therapeutics, Inc.股票老虎,Larimar Therapeutics, Inc.股票老虎国际,Larimar Therapeutics, Inc.行情,Larimar Therapeutics, Inc.股票行情,Larimar Therapeutics, Inc.股价,Larimar Therapeutics, Inc.股市,Larimar Therapeutics, Inc.股票价格,Larimar Therapeutics, Inc.股票交易,Larimar Therapeutics, Inc.股票购买,Larimar Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Larimar Therapeutics, Inc.(LRMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Larimar Therapeutics, Inc.(LRMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}